A Phase IIa, Randomized, Placebo-controlled, Double-blind, Cross-over Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis, 10011762 Intervention: Drug: Anakinra Sponsor: Heidelberg University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials